CBFC: Sunny Deol’s Suryaa Has Not Been Submitted

The Central Board of Film Certification has clarified that Sunny Deol’s upcoming film Suryaa Ant Se Aarambh Tak has not been submitted for certification, the Ministry of Information and Broadcasting said. The statement followed a strongly worded letter from the Indian Medical Association to Union Minister Ashwini Vaishnaw, objecting to how the film portrays the medical profession.

For fans, that means the film is still in the pre-clearance stage at a moment when its teaser has already drawn formal pushback from doctors.

What the IMA has objected to

In its letter dated October 22, the IMA said the promotional content raised concerns about ‘generalisation of corruption within healthcare’ and the depiction of violence against medical professionals. The association argued that such scenes could leave audiences feeling that corruption and unethical practice are widespread in medicine.

It accepted that individual cases of misconduct must be investigated and punished, but said the actions of a few should not tarnish the image of honest, dedicated doctors.

The IMA also pointed to sequences where physical attacks on doctors, nurses and hospital staff appear heroic or justified. The letter said such content may ‘normalise’ violence against healthcare workers who already face safety challenges in hospitals.

What the teaser shows

Unveiled earlier this month, the teaser opens with a personal loss and follows Suryaa as he is drawn into a chain of events connected to the medical system. What begins as a private matter becomes a hunt for a larger truth hidden inside a seemingly legitimate system, according to the makers.

The film stars Sunny Deol with Ravi Kishan, Pragya Jaiswal, Tanushree Chakraborty, Manish Wadhwa, Tinu Anand, Virti Vaghani, Jisshu Sengupta, Khalid Siddiqui, Anoop Trivedi and Rohit Tiwari. It is currently scheduled to release in theatres on November 20.

What the IMA wants

• An impartial review of the film’s content and its portrayal of doctors.
• Corrective steps from the filmmakers over generalisation of misconduct and doctor-directed violence.
• Consideration of a ban or other fitting action if justified under law.

The IMA made it clear it does not support corruption or unprofessional conduct. It wants any wrongdoing to be handled through legal and disciplinary channels.

Why this matters

This face-off has landed before the CBFC has even taken a call. In India, a feature film must be certified before theatrical release, so the certification status is the next procedural milestone to watch. But the IMA’s letter has already moved the conversation from the teaser to policy: should a promotional clip be enough to trigger review demands?

For Bollywood, this is another example of how a teaser can become the battleground. The film’s marketing frames Suryaa as a man uncovering a hidden truth, but doctors see the same scenes as a risk to their safety. That gap between creative intent and professional perception is where censorship debates usually begin.

Fans awaiting the Sunny Deol actioner should watch for two updates: whether the makers respond to the IMA, and when the film actually goes before the CBFC. Both will signal whether the November 20 date holds.

Source: The Times of India